BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Santiago JA, Potashkin JA. The Impact of Disease Comorbidities in Alzheimer's Disease. Front Aging Neurosci 2021;13:631770. [PMID: 33643025 DOI: 10.3389/fnagi.2021.631770] [Cited by in Crossref: 6] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Green SF, Frame T, Banerjee LV, Gimson A, Blackman J, Morrison H, Lloyd K, Rudd S, Frederick Fotherby WG, Bartsch U, Purcell S, Jones M, Coulthard L. A systematic review of the validity of non-invasive sleep-measuring devices in mid-to-late life adults: Future utility for Alzheimer's disease research. Sleep Medicine Reviews 2022. [DOI: 10.1016/j.smrv.2022.101665] [Reference Citation Analysis]
2 Sriram S, Mehkri Y, Quintin S, Lucke-wold B. Shared pathophysiology: Understanding stroke and Alzheimer’s disease. Clinical Neurology and Neurosurgery 2022;218:107306. [DOI: 10.1016/j.clineuro.2022.107306] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Carlyle BC, Kitchen RR, Mattingly Z, Celia AM, Trombetta BA, Das S, Hyman BT, Kivisäkk P, Arnold SE. Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease. Front Neurol 2022;13:889647. [DOI: 10.3389/fneur.2022.889647] [Reference Citation Analysis]
4 Santiago JA, Quinn JP, Potashkin JA. Physical Activity Rewires the Human Brain against Neurodegeneration. Int J Mol Sci 2022;23:6223. [PMID: 35682902 DOI: 10.3390/ijms23116223] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Hawksworth J, Fernández E, Gevaert K. A new generation of AD biomarkers: 2019 to 2021. Ageing Res Rev 2022;79:101654. [PMID: 35636691 DOI: 10.1016/j.arr.2022.101654] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Fernández-Bolaños JG, López Ó. Butyrylcholinesterase inhibitors as potential anti-Alzheimer's agents: an updated patent review (2018-present). Expert Opin Ther Pat 2022. [PMID: 35623095 DOI: 10.1080/13543776.2022.2083956] [Reference Citation Analysis]
7 Piccialli I, Tedeschi V, Caputo L, D’errico S, Ciccone R, De Feo V, Secondo A, Pannaccione A. Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes. Front Pharmacol 2022;13:876614. [DOI: 10.3389/fphar.2022.876614] [Reference Citation Analysis]
8 Alastalo A, Tolppanen AM, Nietola M, Haapea M, Miettunen J, Hartikainen S, Jääskeläinen E. Prevalence and characteristics of psychiatric morbidity treated in specialized health care in a nationwide cohort of people with newly diagnosed Alzheimer's disease. Acta Psychiatr Scand 2022;145:507-16. [PMID: 35266140 DOI: 10.1111/acps.13423] [Reference Citation Analysis]
9 Podsiedlik M, Markowicz-Piasecka M, Sikora J. The Influence of Selected Antipsychotic Drugs on Biochemical Aspects of Alzheimer's Disease. Int J Mol Sci 2022;23:4621. [PMID: 35563011 DOI: 10.3390/ijms23094621] [Reference Citation Analysis]
10 Young A, Hunt T, Ericson M. The Slowest Shared Resonance: A Review of Electromagnetic Field Oscillations Between Central and Peripheral Nervous Systems. Front Hum Neurosci 2022;15:796455. [DOI: 10.3389/fnhum.2021.796455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ederer ML, Günther M, Best L, Lindner J, Kaleta C, Witte OW, Simon R, Frahm C. Voluntary Wheel Running in Old C57BL/6 Mice Reduces Age-Related Inflammation in the Colon but Not in the Brain. Cells 2022;11:566. [PMID: 35159375 DOI: 10.3390/cells11030566] [Reference Citation Analysis]
12 Tang AS, Oskotsky T, Havaldar S, Mantyh WG, Bicak M, Solsberg CW, Woldemariam S, Zeng B, Hu Z, Oskotsky B, Dubal D, Allen IE, Glicksberg BS, Sirota M. Deep phenotyping of Alzheimer's disease leveraging electronic medical records identifies sex-specific clinical associations. Nat Commun 2022;13:675. [PMID: 35115528 DOI: 10.1038/s41467-022-28273-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Eggert S, Kins S, Endres K, Brigadski T. Brothers in arms: proBDNF/BDNF and sAPPα/Aβ-signaling and their common interplay with ADAM10, TrkB, p75NTR, sortilin, and sorLA in the progression of Alzheimer's disease. Biol Chem 2022;403:43-71. [PMID: 34619027 DOI: 10.1515/hsz-2021-0330] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Shim S, Koh YH, Kim J, Jeon J. A combination of multiple autoantibodies is associated with the risk of Alzheimer’s disease and cognitive impairment. Sci Rep 2022;12. [DOI: 10.1038/s41598-021-04556-2] [Reference Citation Analysis]
15 Li X, Li J, Huang Y, Gong Q, Fu Y, Xu Y, Huang J, You H, Zhang D, Zhang D, Mao F, Zhu J, Wang H, Zhang H, Li J. The novel therapeutic strategy of vilazodone-donepezil chimeras as potent triple-target ligands for the potential treatment of Alzheimer's disease with comorbid depression. Eur J Med Chem 2021;229:114045. [PMID: 34922191 DOI: 10.1016/j.ejmech.2021.114045] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Cojocaru A, Zavaleanu AD, Călina DC, Gheonea DI, Osiac E, Boboc IKS, Mitran SI. Different Age Related Neurological and Cardiac Effects of Verapamil on a Transgenic Mouse Model of Alzheimer's Disease. Curr Health Sci J 2021;47:263-9. [PMID: 34765247 DOI: 10.12865/CHSJ.47.02.17] [Reference Citation Analysis]
17 Readman MR, Polden M, Gibbs MC, Wareing L, Crawford TJ. The Potential of Naturalistic Eye Movement Tasks in the Diagnosis of Alzheimer's Disease: A Review. Brain Sci 2021;11:1503. [PMID: 34827502 DOI: 10.3390/brainsci11111503] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Butler LM, Houghton R, Abraham A, Vassilaki M, Durán-Pacheco G. Comorbidity Trajectories Associated With Alzheimer's Disease: A Matched Case-Control Study in a United States Claims Database. Front Neurosci 2021;15:749305. [PMID: 34690684 DOI: 10.3389/fnins.2021.749305] [Reference Citation Analysis]
19 Gonzales MM, Krishnamurthy S, Garbarino V, Daeihagh AS, Gillispie GJ, Deep G, Craft S, Orr ME. A geroscience motivated approach to treat Alzheimer's disease: Senolytics move to clinical trials. Mech Ageing Dev 2021;200:111589. [PMID: 34687726 DOI: 10.1016/j.mad.2021.111589] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
20 Chung Y, Lee H; the Alzheimer’s Disease Neuroimaging Initiative. Correlation between Alzheimer's disease and type 2 diabetes using non-negative matrix factorization. Sci Rep 2021;11:15265. [PMID: 34315930 DOI: 10.1038/s41598-021-94048-0] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Varano F, Catarzi D, Vigiani E, Dal Ben D, Buccioni M, Marucci G, Di Cesare Mannelli L, Lucarini E, Ghelardini C, Volpini R, Colotta V. Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A1 and A2A Receptors, and Efficacy in Animal Models of Depression. Pharmaceuticals (Basel) 2021;14:657. [PMID: 34358083 DOI: 10.3390/ph14070657] [Reference Citation Analysis]
22 Mhatre PG, Lee JH, Pang D, Zigman WB, Tycko B, Krinsky-McHale SJ, Yang Y, Silverman W, Schupf N. The Association between Sex and Risk of Alzheimer's Disease in Adults with Down Syndrome. J Clin Med 2021;10:2966. [PMID: 34279450 DOI: 10.3390/jcm10132966] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
23 Maciejewska K, Czarnecka K, Szymański P. A review of the mechanisms underlying selected comorbidities in Alzheimer's disease. Pharmacol Rep 2021. [PMID: 34121170 DOI: 10.1007/s43440-021-00293-5] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
24 Litwiniuk A, Bik W, Kalisz M, Baranowska-Bik A. Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer's Disease. Int J Mol Sci 2021;22:5603. [PMID: 34070553 DOI: 10.3390/ijms22115603] [Cited by in F6Publishing: 4] [Reference Citation Analysis]